tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

QTTB Stock Latest News

Q32 Bio Appoints New Interim Chief Medical Officer
Company AnnouncementsQ32 Bio Appoints New Interim Chief Medical Officer
3d ago
8K
QTTB
Q32 Bio chief medical officer Jason Campagna to depart
PremiumThe Fly
Q32 Bio chief medical officer Jason Campagna to depart
3d ago
QTTB
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
PremiumThe Fly
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
5d ago
QTTB
Q32 Bio Stockholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
Q32 Bio Stockholders Approve Key Proposals at Annual Meeting
11d ago
8K
QTTB
Q32 Bio Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Q32 Bio Inc. Reports Q1 2025 Financial Results
2M ago
QTTB
Q32 Bio granted Fast Track designation for bempikibart
PremiumThe FlyQ32 Bio granted Fast Track designation for bempikibart
2M ago
QTTB
Q32 Bio Board Member Mark Iwicki Resigns
Premium
Company Announcements
Q32 Bio Board Member Mark Iwicki Resigns
2M ago
8K
QTTB
Q32 Bio doses first patient in both parts of SIGNAL-AA trial
Premium
The Fly
Q32 Bio doses first patient in both parts of SIGNAL-AA trial
2M ago
QTTB
Q32 Bio price target lowered to $15 from $16 at Wells Fargo
PremiumThe Fly
Q32 Bio price target lowered to $15 from $16 at Wells Fargo
4M ago
QTTB
Q32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
PremiumCompany Announcements
Q32 Bio Inc’s Intellectual Property Challenges: Navigating Risks and Competitive Pressures
4M ago
QTTB
Q32 Bio Reports Promising Trial Results and Financials
PremiumCompany Announcements
Q32 Bio Reports Promising Trial Results and Financials
4M ago
QTTB
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
PremiumThe Fly
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
4M ago
QTTB
Cautious Optimism: Q32 Bio’s Strategic Shift to Focus on Bempikibart for Alopecia Areata
PremiumRatingsCautious Optimism: Q32 Bio’s Strategic Shift to Focus on Bempikibart for Alopecia Areata
5M ago
QTTB
IBM initiated, Southwest upgraded: Wall Street’s top analyst calls
Premium
The Fly
IBM initiated, Southwest upgraded: Wall Street’s top analyst calls
5M ago
EFX
IBM
Q32 Bio downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
Q32 Bio downgraded to Market Perform from Outperform at BMO Capital
5M ago
QTTB
Q32 Bio downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Q32 Bio downgraded to Neutral from Overweight at Piper Sandler
5M ago
QTTB
Q32 Bio Restructures to Focus on Bempikibart Development
PremiumCompany Announcements
Q32 Bio Restructures to Focus on Bempikibart Development
5M ago
8K
QTTB
Q32 Bio announces corporate restructuring to focus on bempikibart
PremiumThe Fly
Q32 Bio announces corporate restructuring to focus on bempikibart
5M ago
QTTB
Q32 Bio Advances Clinical Trials for Growth Opportunities
PremiumCompany Announcements
Q32 Bio Advances Clinical Trials for Growth Opportunities
6M ago
8K
QTTB
Q32 Bio price target lowered to $22 from $64 at BMO Capital
PremiumThe FlyQ32 Bio price target lowered to $22 from $64 at BMO Capital
7M ago
QTTB
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
Premium
The Fly
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
7M ago
QTTB
Q32 Bio downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Q32 Bio downgraded to Neutral from Buy at Guggenheim
7M ago
QTTB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >